PMC:7094172 / 25974-26075
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T409 | 71-75 | CHEBI:23888;CHEBI:23888;GO:0017144 | denotes | drug |
T408 | 76-87 | GO:0017144 | denotes | development |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T128 | 43-51 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T196 | 65-66 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T218 | 43-51 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T219 | 71-75 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T200 | 0-101 | Sentence | denotes | Thus, non-native interaction interfaces in proteins may comprise a new drug development target class. |